http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112798727-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-8813 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-88 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88 |
| filingDate | 2021-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112798727-B |
| titleOfInvention | Biomarker F7 for the diagnosis of white matter lesions and its application |
| abstract | The present invention provides biomarkers for diagnosing cerebral white matter lesions and applications thereof, the biomarkers are ceramide (d18:0/24:1(15Z)) (Cer(d18:0/24:1(15Z)) )). The biomarker ceramide (d18:0/24:1(15Z)) is combined with cholesterol-α-D-glucoside (Cholesteryl-alpha-D-glucoside) and binds 6Z, 9Z, 20-eicosan alkenoic acid (6Z, 9Z, 20‑Heneicosatriene), Cannflavin A, Cucurbitacin E or Cholesterol ester 22:6 (22:6 Cholesterol ester) to determine the presence of white matter lesions. A biological marker for diagnosing cerebral white matter lesions is used for preparing detection reagents for diagnosing cerebral white matter lesions, which is helpful for diagnosing whether there is a tendency of cerebral white matter lesions and preventing them in advance. |
| priorityDate | 2021-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.